Scientists test which dose fights thyroid cancer best
NCT ID NCT01496313
Summary
This study aimed to find the better dose of the drug vandetanib for people with advanced medullary thyroid cancer that was growing or causing symptoms. It involved 81 patients who were randomly assigned to receive either a 150mg or 300mg daily dose. The main goal was to compare how well the cancer responded to each dose and to understand the side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number : 1901
Prague, 15006, Czechia
-
Investigational Site Number : 1903
Olomouc, 77900, Czechia
-
Investigational Site Number : 5703
Gliwice, 44-101, Poland
-
Investigational Site Number : 5704
Warsaw, Masovian Voivodeship, 02-781, Poland
-
Research Site
Houston, Texas, United States
-
Research Site
Olomouc, Czechia
-
Research Site
Prague, Czechia
-
Research Site
Bangalore Karnataka, India
-
Research Site
Vellore, India
-
Research Site
Beersheba, Israel
-
Research Site
Haifa, Israel
-
Research Site
Jerusalem, Israel
-
Research Site
Petah Tikva, Israel
-
Research Site
Catania, Italy
-
Research Site
Milan, Italy
-
Research Site
Palermo, Italy
-
Research Site
Pisa, Italy
-
Research Site
Roma, Italy
-
Research Site
Siena, Italy
-
Research Site
Torino, Italy
-
Research Site
Groningen, Netherlands
-
Research Site
Leiden, Netherlands
-
Research Site
Gliwice, Poland
-
Research Site
Warsaw, Poland
-
Research Site
Zgierz, Poland
-
Research Site
Saint Petersburg, Russia
-
Research Site
Cardiff, United Kingdom
-
Research Site
Greater London, United Kingdom
-
Research Site
London, United Kingdom
-
Research Site
Tyne & Wear, United Kingdom
Conditions
Explore the condition pages connected to this study.